Baseline risk of recurrence in stage I–II endometrial carcinoma

OBJECTIVE: Though there are no evidences that postoperative therapy improves overall survival (OS) in stage I–II endometrial carcinoma, many women receive postoperative radiation or chemotherapy. This study aimed to investigate the baseline risk of recurrence after complete resection without any adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasada, Shinsuke, Yunokawa, Mayu, Takehara, Yae, Ishikawa, Mitsuya, Ikeda, Shunichi, Kato, Tomoyasu, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709535/
https://www.ncbi.nlm.nih.gov/pubmed/29185267
http://dx.doi.org/10.3802/jgo.2018.29.e9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709535/
https://www.ncbi.nlm.nih.gov/pubmed/29185267
http://dx.doi.org/10.3802/jgo.2018.29.e9

Ejemplares similares